KM
Keren Mano Tamir, MD
Head of Scientific Strategy, Communications and Business Development
Everads TherapyTherapeutic Areas
Everads Therapy Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VV-14295 | Geographic atrophy (dry AMD) | Phase 1 |
Leadership Team at Everads Therapy
MW
Moshe Weinstein
Executive Chair & CEO
HD
Hagay Drori
CTO
YC
Yonatan Cohavi
CFO
AI
Alla Iserlis
Head of QA
MM
Miriam Mangelus, PhD, MBA
Head of R&D Search and Evaluation
AB
Adi Bigger Hoggeg
Head of Clinical Operations
YB
Yoreh Barak, MD
Scientific Advisory Board, Head of Retina at Rambam Medical Center